drugset
drugset / Trial / NCT03875274

Morphine Added to Ropivacaine for FICB for Postoperative Analgesia

NCT03875274 ↗

Phase 4 Completed 70 enrolled B.P. Koirala Institute of Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB

Timeline

Start
2017-04-01
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 2 ml Other
Background Ropivacaine Other / unclassified 0.375 % Other
Background Ropivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.